Skip to main content
HCPCS J2820 · Level II · Part B drug

J2820: sargramostim (Leukine), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2820

Billing unit
50 MCG
Sargramostim injection
ASP payment limit
$62.47
October 2026; -0.0% vs July 2026
Practitioner MUE
15
MAI 3
OPPS status
SI K
APC 0731
NCCI exposure
no PTP pairs
Coverage articles
1
4 states

TL;DR

HCPCS J2820 is the Level II code for Injection, sargramostim (gm-csf), 50 mcg, billed per 50 MCG. The Medicare Part B ASP payment limit for October 2026 is $62.47 per billing unit, down 0.0% from July 2026. The practitioner MUE allows up to 15 units per date of service (MAI 3), so a full 15-unit day is $937.05 at the current limit. Under OPPS it carries status indicator K in APC 0731. J2820 is billed in units of 50 MCG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 1 NDC to it, sold as Leukine by Partner Therapeutics, Inc. 1 Medicare coverage article lists the code across 4 states, including A56748.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2820 at $62.47 per 50 MCG for October 2026, derived from manufacturer average sales price plus 6%, compared with $62.474 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2820
QuarterPayment limitPerCoinsurance
October 2026$62.4750 MCG20%
July 2026$62.47450 MCG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J2820. Report the NDC in the claim's drug segment and bill the number of J2820 units that equals the quantity administered divided by 50 MCG; the last column gives units per full package.

NDCs that crosswalk to J2820
NDCDrug nameLabelerPackage sizeBilling units / package
71837-5843-05LeukinePartner Therapeutics, Inc1 × 525

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2820. For practitioners the limit is 15 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2820 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services153 Date of Service Edit: ClinicalClinical: Data
Facility outpatient hospital103 Date of Service Edit: ClinicalClinical: Data
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J2820 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2820 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2820 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2820 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J2820 in their HCPCS tables, covering 4 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J2820
ArticleTitleContractor(s)StatesRelated LCD
A56748Billing and Coding: White Cell Colony Stimulating FactorsPalmetto GBANC SC VA WVL37176

Diagnoses Medicare contractors cover for J2820

One billing and coding article attaches a covered diagnosis list to J2820: 30 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J2820
ICD-10-CMDescription (FY2027)Articles covering
D61.2Aplastic anemia due to other external agents1 of 1
D61.818Other pancytopenia1 of 1
D70.8Other neutropenia1 of 1
Z51.89Encounter for other specified aftercare1 of 1
C91.00Acute lymphoblastic leukemia not having achieved remission1 of 1
C91.01Acute lymphoblastic leukemia, in remission1 of 1
C91.02Acute lymphoblastic leukemia, in relapse1 of 1
C96.20Malignant mast cell neoplasm, unspecified1 of 1
C96.21Aggressive systemic mastocytosis1 of 1
C96.22Mast cell sarcoma1 of 1
C96.29Other malignant mast cell neoplasm1 of 1
D46.0Refractory anemia without ring sideroblasts, so stated1 of 1
D46.1Refractory anemia with ring sideroblasts1 of 1
D46.20Refractory anemia with excess of blasts, unspecified1 of 1
D46.21Refractory anemia with excess of blasts 11 of 1
15 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J2820 are counted here: a group whose instructions name J2820, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J2820, by article
ArticleContractorGroups that applyCovered codes for J2820Full list
A56748Palmetto GBA5 groups apply to J282030On LCD L37176

Local coverage policies that list J2820

1 active Local Coverage Determination lists J2820 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2820 carries status indicator K and is assigned to APC 0731, with a published national unadjusted payment of $62.47. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2820 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $62.47 per 50 MCG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J2820 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2820

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2820

What does HCPCS code J2820 describe?

J2820 is defined by CMS as "Injection, sargramostim (gm-csf), 50 mcg". Each billing unit represents 50 MCG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2820 a CPT code?

No. J2820 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as sargramostim (Leukine); CPT codes are five-character codes maintained by the AMA. On a Part B claim J2820 reports the drug itself in 50 mcg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2820 in October 2026?

The ASP-based payment limit is $62.47 per 50 MCG, with 20% beneficiary coinsurance. The July 2026 limit was $62.474. Commercial payers use their own fee schedules.

How many units of J2820 can be billed per day?

The practitioner Medically Unlikely Edit is 15 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 10. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.

Which NDCs map to J2820?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Leukine (Partner Therapeutics, Inc). For example NDC 71837-5843-05 (package size 1) equals 25 billing units of J2820.

Does J2820 have NCCI bundling edits?

No active practitioner PTP pairs list J2820 as a column-1 or column-2 code in the v323r0 release.

Which Medicare coverage articles mention J2820?

1 current Billing and Coding Article in the Medicare Coverage Database lists J2820, covering 4 states: A56748 (Billing and Coding: White Cell Colony Stimulating Factors).

What diagnosis codes support J2820?

One Medicare billing and coding article lists 30 covered ICD-10-CM codes for J2820, for example D61.2 (Aplastic anemia due to other external agents); D61.818 (Other pancytopenia); D70.8 (Other neutropenia); Z51.89 (Encounter for other specified aftercare); C91.00 (Acute lymphoblastic leukemia not having achieved remission). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.